We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$38.5M +$41.5M +814,408 New
Invesco
27
Invesco
Georgia
$34.1M +$36.7M +720,596 New
Norges Bank
28
Norges Bank
Norway
$33M +$35.5M +697,329 New
TCIM
29
TIAA CREF Investment Management
New York
$32.8M +$35.4M +694,271 New
RJA
30
Raymond James & Associates
Florida
$32.7M +$35.2M +690,834 New
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$31.5M +$33.9M +666,475 New
BIM
32
BlackRock Investment Management
Delaware
$30.6M +$32.9M +646,862 New
JP Morgan Chase
33
JP Morgan Chase
New York
$28.1M +$30.3M +594,165 New
MNA
34
Manning & Napier Advisors
New York
$24.2M +$26.1M +511,667 New
PI
35
Putnam Investments
Massachusetts
$23.9M +$25.7M +505,065 New
AAMU
36
Amundi Asset Management US
Massachusetts
$22.6M +$24.3M +477,061 New
GT
37
Glenmede Trust
Pennsylvania
$21.6M +$23.3M +457,182 New
First Manhattan
38
First Manhattan
New York
$21.6M +$21.7M +427,029 New
HI
39
Honeywell International
North Carolina
$21M +$22.7M +445,000 New
GC
40
Guggenheim Capital
Illinois
$19.8M +$21.4M +419,291 New
Northern Trust
41
Northern Trust
Illinois
$19.3M +$20.8M +407,895 New
ACI
42
AMP Capital Investors
Australia
$18.4M +$19.5M +382,741 New
HSA
43
Hussman Strategic Advisors
Maryland
$17.7M +$19.1M +375,000 New
Bank of America
44
Bank of America
North Carolina
$17M +$18.3M +358,954 New
CC
45
Chubb Corp
New Jersey
$16.6M +$17.8M +350,000 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$15.2M +$16.4M +321,327 New
N
47
Nuveen
North Carolina
$14.1M +$15.2M +298,651 New
Millennium Management
48
Millennium Management
New York
$14M +$15M +295,444 New
Deutsche Bank
49
Deutsche Bank
Germany
$13.8M +$14.9M +292,069 New
Goldman Sachs
50
Goldman Sachs
New York
$13M +$14M +274,009 New
1
2
3 4 5

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.